Your session is about to expire
← Back to Search
NIR178 for Kidney Cancer
Study Summary
This trial is testing a new drug combo to treat various solid tumors and a type of lymphoma. They want to see if it's effective and safe, and also figure out the best way to give the drugs.
- Kidney Cancer
- Pancreatic Cancer
- Head and Neck Cancers
- Non-Hodgkin's Lymphoma
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Bladder Cancer
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 1 & 2 trial • 172 Patients • NCT02325739Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many clinical facilities are currently conducting this trial?
"This clinical trial is running in various locations, including the University of Wisconsin in Madison, WI; H Lee Moffitt Cancer Centre and Research Institute Inc. located near Tampa, FL; as well as Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins situated close to Baltimore, MD."
Have any preceding investigations been conducted with NIR178?
"At present, there are 27 open clinical trials examining the efficacy of NIR178. Notably, one of these investigations has reached Phase 3 and is being conducted at locations across 508 cities, with several taking place in New york City."
Is this the inaugural endeavor of its type?
"Presently, there are 27 energetic investigations for NIR178 across 35 countries and 122 cities. The inaugural trial of the drug was launched in 2011 by Novartis Pharmaceuticals and included 185 members; completing its Phase 1 endorsement stage. Subsequent to this foray, an additional 21 experiments have been accomplished."
How many subjects are being recruited for participation in this clinical research?
"This investigation is no longer recruiting participants, having been posted on August 28th 2017 and last updated on November 25th 2022. For those looking for a related clinical trial, there are 4324 studies enrolling patients with melanoma as well as 27 trails involving NIR178 that still need volunteers."
Are there opportunities for prospective participants to join this research?
"Clinicaltrials.gov data confirms that this study, posted on August 28th 2017 and last updated November 25th 2022, is not presently searching for participants. However, there are a plethora of other medical trials actively recruiting patients right now - 4351 to be exact."
What potential adverse effects might patients experience with NIR178?
"NIR178's safety has been established to a degree, so it was assigned a score of 2 due to its status as being in the second phase of clinical trials and thus lacking efficacy data."
Share this study with friends
Copy Link
Messenger